Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 4 |
Descriptor
Schizophrenia | 4 |
Adolescents | 3 |
Brain | 2 |
Brain Hemisphere Functions | 2 |
Children | 2 |
Comparative Analysis | 2 |
Patients | 2 |
Adults | 1 |
At Risk Persons | 1 |
Attention | 1 |
Communication Skills | 1 |
More ▼ |
Source
Journal of the American… | 4 |
Author
Publication Type
Journal Articles | 4 |
Reports - Research | 2 |
Opinion Papers | 1 |
Reports - Descriptive | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Kumra, Sanjiv; Robinson, Paul; Tambyraja, Rabindra; Jensen, Daniel; Schimunek, Caroline; Houri, Alaa; Reis, Tiffany; Lim, Kelvin – Journal of the American Academy of Child & Adolescent Psychiatry, 2012
Objective: In early-onset schizophrenia (EOS), the earliest structural brain volumetric abnormalities appear in the parietal cortices. Early exposure to cannabis may represent an environmental risk factor for developing schizophrenia. This study characterized cerebral cortical gray matter structure in adolescents in regions of interest (ROIs) that…
Descriptors: Marijuana, Schizophrenia, Brain, At Risk Persons
Kumra, Sanjiv – Journal of the American Academy of Child & Adolescent Psychiatry, 2008
The article describes the use of structural neuroimaging to understand the psychopathology of childhood-onset schizophrenia. Results showed an increase in lateral volumes, reduced total and regional volumes of gray matter in the cortex and increased basal ganglia volumes as in adult-onset schizophrenia in comparison with healthy subjects.
Descriptors: Psychopathology, Schizophrenia, Diagnostic Tests, Brain
Findling, Robert L.; Frazier, Jean A.; Gerbino-Rosen, Ginny; Kranzler, Harvey N.; Kumra, Sanjiv; Kratochvil, Christopher J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
This article presents responses to the question of whether clozapine is ever appropriate to use in the pediatric population. Among others, Jean A. Frazier also agreed that clozapine is appropriate for use in the pediatric population. Clozapine has truly revolutionized the treatment of refractory patients with schizophrenia at any age. This agent…
Descriptors: Patients, Adolescents, Schizophrenia, Pediatrics
Cervellione, Kelly L.; Burdick, Katherine E.; Cottone, John G.; Rhinewine, Joseph P.; Kumra, Sanjiv – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: Previous cross-sectional studies in adolescents with early-onset schizophrenia (EOS; onset of psychotic symptoms by 18 years of age) have reported patterns of generalized neurocognitive deficits as compared to healthy comparison subjects (HCSs). Here, the authors examined the longitudinal stability of neuropsychological deficits in…
Descriptors: Schizophrenia, Adolescents, Patients, Neuropsychology